Article Details

Brainstorm Cell Therapeutics (NASDAQ:BCLI) Upgraded to “Buy” by ValuEngine

Retrieved on: 2020-01-06 19:26:15

Tags for this article:

Click the tags to see associated articles and topics

Brainstorm Cell Therapeutics (NASDAQ:BCLI) Upgraded to “Buy” by ValuEngine. View article details on hiswai:

Excerpt

<div>Finally, <b>Renaissance Technologies</b> LLC lifted its holdings in Brainstorm Cell Therapeutics by 10.7% during the second quarter. <b>Renaissance</b> ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up